German-based Eurox Group has entered into an exclusive agreement with the US multi-state Orchid Ventures.
Under the agreement, Eurox, PurTec and JWEI, the company’s original equipment manufacturer (OEM) supplier and partner, will submit one of PurTec’s premium disposable vaporiser devices to authorities in Germany for Medical Device Approval.
The agreement is PurTec’s first European project.
Read more: Eurox begins sale of cannabis products in Germany
Founder, CEO and chairman of Orchid, Corey Mangold, commented: “After months of planning and strategising, we are pleased to announce our partnership with such an established group in Eurox.
“We’re thrilled to join forces with Eurox and to be submitting one of our most stringently tested vaping products for Medical Device Approval with German health authorities.
“Once the product is accepted, this will be a huge step forward in our ability to deliver one of the first vaping products to patients and consumers in Germany along with several other European countries.
“We are confident that with the combined experience and expertise of Eurox and JWEI, we will succeed in getting approval and be among one of the first vaporiser products in-market and available to consumers throughout the EU.”
Read more: Materia enters agreement with Eurox for cannabis extract distribution
The companies will be working on several requirements and safety studies to prove the efficacy and safety of the device, and have already begun securing various certifications to speed up the approval process.
If and when approval is given for the device Eurox will have exclusivity regarding sales and distribution of the PurTec product in the European Union, United Kingdom and Brazil.
Co-CEO of Eurox, Dr Bernhard Babel, commented: “We are excited about this partnership.
“We believe that PurTec and JEWI will be valuable, long-term partners that can help us expand access to relevant and exciting new products that will compliment our portfolio and advance our growth trajectory.
“Our objective is to deliver with liquid vaping a controlled and consistent therapy form to patients with need for inhaling in Europe and beyond.”
[activecampaign form=31]
